中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy

文献类型:期刊论文

作者Zhou, Lei1,3; Yi, Wenzhe1,5; Zhang, Zehong4,5; Shan, Xiaoting1,5; Zhao, Zitong1; Sun, Xiangshi1; Wang, Jue1,5; Wang, Hao3; Jiang, Hualiang4,5; Zheng, Mingyue4,5
刊名NATIONAL SCIENCE REVIEW
出版日期2023-09-04
卷号10期号:10页码:16
ISSN号2095-5138
关键词vaccine mRNA STING cancer immunotherapy nanoparticles
DOI10.1093/nsr/nwad214
通讯作者Zheng, Mingyue(myzheng@simm.ac.cn) ; Wang, Dangge(dgwang@shsmu.edu.cn) ; Li, Yaping(ypli@simm.ac.cn)
英文摘要Messenger RNA (mRNA) vaccine is revolutionizing the methodology of immunization in cancer. However, mRNA immunization is drastically limited by multistage biological barriers including poor lymphatic transport, rapid clearance, catalytic hydrolysis, insufficient cellular entry and endosome entrapment. Herein, we design a mRNA nanovaccine based on intelligent design to overcome these obstacles. Highly efficient nanovaccines are carried out with machine learning techniques from datasets of various nanocarriers, ensuring successful delivery of mRNA antigen and cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) to targets. It activates stimulator of interferon genes (STING), promotes mRNA-encoded antigen presentation and boosts antitumour immunity in vivo, thus inhibiting tumour growth and ensuring long-term survival of tumour-bearing mice. This work provides a feasible and safe strategy to facilitate STING agonist-synergized mRNA immunization, with great translational potential for enhancing cancer immunotherapy. This paper provides a rational design option to develop mRNA nanovaccine with machine learning techniques, leading to effective stimulator of interferon genes (STING) agonist-synergized mRNA immunization.
WOS关键词DELIVERY
资助项目National Key Ramp;D Program of China[2022YFC3401404] ; National Natural Science Foundation of China[32170935] ; National Natural Science Foundation of China[31930066] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[2019283]
WOS研究方向Science & Technology - Other Topics
语种英语
出版者OXFORD UNIV PRESS
WOS记录号WOS:001058732500003
源URL[http://119.78.100.183/handle/2S10ELR8/307019]  
专题新药研究国家重点实验室
通讯作者Zheng, Mingyue; Wang, Dangge; Li, Yaping
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res & Ctr Pharmaceut, Shanghai 201203, Peoples R China
2.Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Precis Res Ctr Refractory Dis, Sch Med, Shanghai 201620, Peoples R China
3.China State Inst Pharmaceut Ind, Shanghai 201203, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China
5.Univeris Chinese Acad Sci, Beijing 100049, Peoples R China
6.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264000, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Lei,Yi, Wenzhe,Zhang, Zehong,et al. STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy[J]. NATIONAL SCIENCE REVIEW,2023,10(10):16.
APA Zhou, Lei.,Yi, Wenzhe.,Zhang, Zehong.,Shan, Xiaoting.,Zhao, Zitong.,...&Li, Yaping.(2023).STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy.NATIONAL SCIENCE REVIEW,10(10),16.
MLA Zhou, Lei,et al."STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy".NATIONAL SCIENCE REVIEW 10.10(2023):16.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。